Octreotide ameliorates intestinal dysmotility by interstitial cells of cajal protection in a rat acute necrotizing pancreatitis model

Pancreas

Volumn 40, Issue 8, 2011, Pages 1226-1233

  Zhou, Hui ^a   Gao, Jun ^a   Wu, Wenbin ^a   Liu, Li ^a   Wei, Lei ^a   Zou, Duowu ^b   Li, Zhaoshen ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

acute necrotizing pancreatitis; ileus; interstitial cells of Cajal; octreotide; small intestine motility; somatostatin

Indexed keywords

OCTREOTIDE; ORNITHINE; STEM CELL FACTOR RECEPTOR;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BOLUS INJECTION; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTERSTITIAL CELL OF CAJAL; INTESTINAL DYSMOTILITY; MALE; MIGRATING MYOELECTRIC COMPLEX; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; GASTROINTESTINAL AGENTS; GASTROINTESTINAL MOTILITY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL CELLS OF CAJAL; MALE; OCTREOTIDE; PANCREATITIS, ACUTE NECROTIZING; PROTO-ONCOGENE PROTEINS C-KIT; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 80054848720     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318220afab     Document Type: Conference Paper

References (38)

1. Pawlikowski M. Physiology of somatostatin. In: Pawlikowski M, ed. Somatostatin Analogs in Diagnostics and Therapy. Austin, TX: Landes Bioscience; 2007:3-5.
2. Corleto VD. Somatostatin and the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2010;17:63-68.
3. Pinter E, Helyes Z, Nemeth J, et al. Somatostatin as an anti-inflammatory neuropeptide: From physiological basis to drug development. In Fischer A, Jancso G, eds. Neurogenic Inflammation, Neuroimmune Biology. Amsterdam: Elsevier BV; 2009:121-134.
4. Zhu ZH, Holt S, el-Lbishi MS, et al. A somatostatin analogue is protective against retrograde bile salt-induced pancreatitis in the rat. Pancreas. 1991;6:609-613.
5. Choi TK, Mok F, Zhan WH, et al. Somatostatin in the treatment of acute pancreatitis: A prospective randomised controlled trial. Gut. 1989;30:223-227.
6. Uhl W, Buchler MW, Malfertheiner P, et al. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut. 1999;45:97-104.
7. Greenberg R, Haddad R, Kashtan H, et al. The effects of somatostatin and octreotide on experimental and human acute pancreatitis. J Lab Clin Med. 2000;135:112-121.
8. Beger HG, Bittner R, Block S, et al. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986;91:433-438.
9. Van Felius ID, Akkermans LM, Bosscha K, et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil. 2003;15:267-276.
10. Wang X, Gong Z, Wu K, et al. Gastrointestinal dysmotility in patients with acute pancreatitis. J Gastroenterol Hepatol. 2003;18:57-62.
11. Haruma K,Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut. 1994;35:1064-1069.
12. Johansson C, Efendic S,Wisén O, et al. Effects of short-time somatostatin infusion on the gastric and intestinal propulsion in humans. Scand J Gastroenterol. 1978;13:481-483.
13. Kvols LK, Moertel CG, O'Connell MJ, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med. 1986;315:663-666.
14. Mourad FH, Gorard D, Thillainayagam AV, et al. Effective treatment of diabetic diarrhea with somatostatin analogue, octreotide. Gut. 1992; 33:1578-1580.
15. O'Donnell LJ, Watson AJ, Cameron D, et al. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther. 1990;4:177-181.
16. Neri M, Cuccurullo F, Marzio L. Effect of somatostatin on gallbladder volume and small intestinal motor activity in humans. Gastroenterology. 1990;98:316-321.
17. Hostein J, Janssens J, Vantrappen G, et al. Somatostatin induces ectopic activity fronts of the migrating motor complex via a local mechanism. Gastroenterology. 1984;87:1004-1008.
18. Schippers E, Janssens J,Vantrappen G, et al. Somatostatin induces ectopic activity fronts via a local intestinal mechanism during fed state or pentagastrin. Am J Physiol. 1986;250:G149YG154.
19. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461-1467.
20. Nakada K, Ikoma A, Suzuki T, et al. Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs. Am J Surg. 1995;169:294-299.
21. Zhou H, Liu L, Bai Y, et al. Damage of the interstitial cells of Cajal and myenteric neurons causing ileus in acute necrotizing pancreatitis rats. Surgery. 2011;149:262-275.
22. Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology. 1996;111:492-515.
23. Sanders KM. Interstitial cells of Cajal at the clinical and scientific interface. J Physiol. 2006;576:683-687.
24. Rakonczay Z Jr, Hegyi P, Dósa S, et al. A new severe acute necrotizing pancreatitis model induced by L-ornithine in rats. Crit Care Med. 2008;36:2117-2127.
25. Shimojima N, Nakaki T, Morikawa Y, et al. Interstitial cells of Cajal in dysmotility in intestinal ischemia and reperfusion injury in rats. J Surg Res. 2006;135:255-261.
26. Hou X, Yin J, Liu J, et al. In vivo gastric and intestinal slow waves in W/WV mice. Dig Dis Sci. 2005;50:1335-1341.
27. Abdu F, Hicks GA, Hennig G, et al. Somatostatin sst(2) receptors inhibit peristalsis in the rat and mouse jejunum. Am J Physiol Gastrointest Liver Physiol. 2002;282:G624YG633.
28. De Man JG, Shatterjee S, De Winter BY, et al. Effect of somatostatin on gastrointestinal motility in Schistosoma mansoni infected mice. Int J Parasitol. 2002;32:1309-1320.
29. Grider JR. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J Pharmacol Exp Ther. 2003;307:460-467.
30. Corleto VD, Severi C, Romano G, et al. Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol Motil. 2006;18:217-225.
31. Corleto VD, Weber HC, Jensen RT. Expression of somatostatin receptor subtypes on guinea pig gastric and colonic smooth muscle cells. Am J Physiol Gastrointest Physiol. 1999;277:G235YG244.
32. Sternini C, Wong H, Wu SV, et al. Somatostatin 2A receptor is expressed by enteric neurons, and by interstitial cells of Cajal and enterochromaffin-like cells of the gastrointestinal tract. J Comp Neurol. 1997;386:396-408.
33. Bercik P, Bouley L, Dutoit P, et al. Quantitative analysis of intestinal motor patterns: Spatiotemporal organization of nonneural pacemaker sites in the rat ileum. Gastroenterology. 2000;119:386-394.
34. Jiménez M, Vergara P, Christinck F, et al. Mechanism of action of somatostatin on the canine ileal circular muscle. Am J Physiol. 1995;269:G22YG28.
35. Que RS, Cao LP, Ding GP, et al. Correlation of nitric oxide and other free radicals with the severity of acute pancreatitis and complicated systemic inflammatory response syndrome. Pancreas. 2010;39: 536-540.
36. Jenkins SA, Berein A. Review article: The relative effectiveness of somatostatin and octreotide therapy in pancreatic disease. Aliment Pharmacol Ther. 1995;9:349-361.
37. Kusterer K, Blöchle C, Konrad T, et al. Rat liver injury induced by hypoxic ischemia and reperfusion: Protective action by somatostatin and two derivatives. Regul Pept. 1993;44:251-256.
38. Jiménez-García A, Balongo-García R, Alconero FF, et al. Intestinal wall damage in simple ileus in rabbits: Immune-modulator role of somatostatin. Hepatogastroenterology. 2004;51:1030-1036.